United States SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q __________________________________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2023 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-23661 ROCKWELL MEDICAL, INC. (Exact name of registrant as specified in its c ...

Rockwell Medical, Inc. (NASDAQ:RMTI) Q4 2022 Earnings Conference Call March 30, 2023 8:00 AM ET Company Participants Heather Hunter - Senior Vice President and Chief Corporate Affairs Officer Mark Strobeck - President and Chief Executive Officer Tim Chole - Senior Vice President, Sales and Marketing Paul McGarry - Senior Vice President, Finance and Chief Accounting Officer Conference Call Participants Brandon Folkes - Cantor Fitzgerald Operator Good morning, and welcome to Rockwell Medical's Fourth Quarter ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 000-23661 ROCKWELL MEDICAL, INC. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) 30142 S. Wixom Road, Wixom, Michigan 48393 (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE S ...

Rockwell Medical, Inc. (NASDAQ:RMTI) Q3 2022 Earnings Conference Call November 14, 2022 8:00 AM ET Company Participants Heather Hunter - SVP & Chief Affairs Officer Mark Strobeck - President, CEO & Director Paul McGarry - Senior Vice President, Finance and Chief Accounting Officer Conference Call Participants Brandon Folkes - Cantor Fitzgerald & Co. Raghuram Selvaraju - HC Wainwright & Co. Operator Good morning, and welcome to Rockwell Medical's Third Quarter 2022 Results Conference Call and Webcast. Please ...

United States SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q __________________________________________________ (Mark One) Commission File Number: 000-23661 ROCKWELL MEDICAL, INC. (Exact name of registrant as specified in its charter) Delaware 38-3317208 (State or other jurisdiction of incorporation or organization) 30142 S. Wixom Road, Wixom, Michigan 48393 ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September ...

United States SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q __________________________________________________ (Mark One) Commission File Number: 000-23661 ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to ROCKWELL MEDICAL, INC. (Exact name of registrant as specified in its ch ...

Rockwell Medical, Inc. (NASDAQ:RMTI) Q2 2022 Earnings Conference Call August 15, 2022 8:00 AM ET Company Participants Heather Hunter - SVP & Chief Affairs Officer Mark Strobeck - President, CEO & Director Russell Skibsted - EVP, CFO & Chief Business Officer Conference Call Participants Brandon Folkes - Cantor Fitzgerald & Co. Operator Good morning, and welcome to Rockwell Medical's Second Quarter 2022 Results Conference Call and Webcast. Please note, this event is being recorded. At this time, I would like ...

Rockwell Medical, Inc. (NASDAQ:RMTI) Q1 2022 Earnings Conference Call May 16, 2022 4:15 PM ET Company Participants Jason Finkelstein - Investor Relations Russell Ellison - President and Chief Executive Officer Russell Skibsted - Executive Vice President, Chief Financial Officer and Chief Business Officer Marc Hoffman - Chief Medical Officer Tim Chole - Senior Vice President, Sales and Marketing Conference Call Participants Brandon Folkes - Cantor Fitzgerald Operator Good afternoon, ladies and gentlemen and ...

United States SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 000-23661 ROCKWELL MEDICAL, INC. (Exact name of registrant as specified in its charter) Delaware 38-3317208 (State or other jurisdi ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 For the transition period from to Commission file number 000-23661 ROCKWELL MEDICAL, INC. FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 (Exact name of registrant as specified in its charter) (State or other jurisdiction of ...